Search Results - "Kottakis, John"

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD by Rossi, Andrea, Kristufek, Peter, Levine, Bernard E, Thomson, Moira H, Till, Denise, Kottakis, John, Della Cioppa, Giovanni

“…To compare the efficacy, tolerability, and safety of therapy with formoterol and oral slow-release theophylline (THEO) in patients with COPD. A randomized,…”
Get more information

Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study by Kottakis, John, Cioppa, Giovanni Della, Creemers, Jacques, Greefhorst, Louis, Lecler, Violette, Pistelli, Riccardo, Overend, Tim, Till, Denise, Rapatz, G nter, Le Gros, Vincent, Bouros, Demosthenes, Siafakas, Nikolaos

“…To compare the onset and magnitude of bronchodilation after dry powder inhalations of formoterol fumarate (Foradil Aerolizer) versus salmeterol xinofoate…”
Get full text

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study by D'Urzo, A D, De Salvo, M C, Ramirez-Rivera, A, Almeida, J, Sichletidis, L, Rapatz, G, Kottakis, J

“…To compare the efficacy of adding formoterol or salbutamol to regular ipratropium bromide treatment in COPD patients whose conditions were suboptimally…”
Get more information

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV1 reversibility by Bouros, Demosthenes, Kottakis, John, Gros, Vincent Le, Overend, Tim, Cioppa, Giovanni Della, Siafakas, Nikolaos

“…SUMMARY Background: Recent studies suggest that inspiratory capacity (IC) measured at rest can be used to predict improvements in dyspnea and exercise…”
Get full text

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV^sub 1^ reversibility by Bouros, Demosthenes, Kottakis, John, Vincent Le Gros, Overend, Tim

“…BACKGROUND: Recent studies suggest that inspiratory capacity (IC) measured at rest can be used to predict improvements in dyspnea and exercise tolerance in…”
Get full text

Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults by Bronsky, Edwin A., Grossman, Jay, Henis, Marc J., Gallo, Paul P., Yegen, Ümit, Cioppa, Giovanni Della, Kottakis, John, Mehra, Sunil

“…Objective: To assess the peak inspiratory flow rate (PIFR) and forced inspiratory vital capacity (FIVC) through the formoterol (Foradil*) Aerolizer* in…”
Get full text

Formoterol Therapy for Chronic Obstructive Pulmonary Disease: A Review of the Literature by Friedman, Mitchell, Cioppa, Giovanni Della, Kottakis, John

“…Numerous clinical trials have investigated the use of formoterol, a long‐acting β2–agonist, for the treatment of chronic obstructive pulmonary disease (COPD)…”
Get full text

A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol by Shapiro, Gail S., Yegen, Ümit, Xiang, Jim, Kottakis, John, Cioppa, Giovanni Della

“…Background: Inhaled short-acting beta 2-adrenoceptor agonists are the most commonly used treatment for the prevention of exercise-induced bronchoconstriction…”
Get full text

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility by Bouros, Demosthenes, Kottakis, John, Le Gros, Vincent, Overend, Tim, Della Cioppa, Giovanni, Siafakas, Nikolaos

“…Recent studies suggest that inspiratory capacity (IC) measured at rest can be used to predict improvements in dyspnea and exercise tolerance in chronic…”
Get full text

Formoterol Delivered via a Dry Powder Inhaler (Aerolizer): Results from Long-term Clinical Trials in Children by Pearlman, David S., Kottakis, John, Till, Denise, Cioppa, Giovanni Della

“…Summary Over 500 children with asthma, aged 5-12 years, have been treated with formoterol fumarate (Foradilt) delivered via the Aerolizer dry powder inhaler in…”
Get full text

Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma by Chuchalin, Alexander G, Manjra, Ahmed I, Rozinova, Nadezhda N, Skopková, Olga, Cioppa, Giovanni Della, Till, Denise, Kaiser, Guenther, Fashola, Taiwo, Kottakis, John

“…The Certihaler is a new multi-dose dry powder inhaler for the delivery of formoterol (Foradil), a long-acting beta(2)-agonist. This dose-ranging study compared…”
Get more information